Animal models of cerebral amyloid angiopathy
- 28 September 2017
- journal article
- review article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 131 (19), 2469-2488
- https://doi.org/10.1042/cs20170033
Abstract
Cerebral amyloid angiopathy (CAA), due to vascular amyloid β (Aβ) deposition, is a risk factor for intracerebral haemorrhage and dementia. CAA can occur in sporadic or rare hereditary forms, and is almost invariably associated with Alzheimer’s disease (AD). Experimental (animal) models are of great interest in studying mechanisms and potential treatments for CAA. Naturally occurring animal models of CAA exist, including cats, dogs and non-human primates, which can be used for longitudinal studies. However, due to ethical considerations and low throughput of these models, other animal models are more favourable for research. In the past two decades, a variety of transgenic mouse models expressing the human Aβ precursor protein (APP) has been developed. Many of these mouse models develop CAA in addition to senile plaques, whereas some of these models were generated specifically to study CAA. In addition, other animal models make use of a second stimulus, such as hypoperfusion or hyperhomocysteinemia (HHcy), to accelerate CAA. In this manuscript, we provide a comprehensive review of existing animal models for CAA, which can aid in understanding the pathophysiology of CAA and explore the response to potential therapies.This publication has 192 references indexed in Scilit:
- VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survivalScientific Reports, 2013
- Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarctsActa Neuropathologica, 2011
- Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive DeclineThe American Journal of Pathology, 2011
- Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in the Arcabeta Mouse Model of Cerebral AmyloidosisJournal of Cerebral Blood Flow & Metabolism, 2011
- Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ miceActa Neuropathologica, 2011
- Cerebral amyloid angiopathy pathology and cognitive domains in older personsAnnals of Neurology, 2010
- Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's diseaseGlia, 2009
- Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's diseaseNeuroscience, 2009
- Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathiesActa Neuropathologica, 2009
- Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid β-protein precursor transgenic miceNeuroscience, 2007